1.0Cancer Research Institutehttps://www.cancerresearch.org/esrich600338<blockquote class="wp-embedded-content" data-secret="HVrDEyJWAQ"><a href="https://www.cancerresearch.org/es/media-room/dna-microarray-identifies-melanoma-survivors">Hundreds of Genes Distinguish Patients Likely to Survive Advanced Melanoma</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.cancerresearch.org/es/media-room/dna-microarray-identifies-melanoma-survivors/embed#?secret=HVrDEyJWAQ" width="600" height="338" title="«Hundreds of Genes Distinguish Patients Likely to Survive Advanced Melanoma» — Cancer Research Institute" data-secret="HVrDEyJWAQ" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://www.cancerresearch.org/wp-includes/js/wp-embed.min.js </script> https://www.cancerresearch.org/wp-content/uploads/2022/06/bcca7829-330c-4dc3-a1d7-6547c811c31f.jpg206136In a recently published paper, researchers led by CRI-funded clinical investigator Dr. Nina Bhardwaj, director of the Tumor Vaccine Program at the NYU Cancer Institute, used DNA-microarray technology that may identify which patients are more likely to survive from advanced melanoma by analyzing the activity of hundreds of genes involved in the immune response and gene proliferation